Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial
Article in Blood Advances (April 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Blood Advances (April 2024)
Book chapter (December 2023)
Article in Leukemia (April 2023)